Estamos no ar no ! Saiba mais
INFI

Infinity Pharmaceuticals, Inc.

Deslistada

INFI foi retirado da bolsa em 13 de setembro de 2023.

 

Sobre: Infinity Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology related treatments. The company operates in only one segment which is drug development.

Funcionários: 30

Notícias

Positivo
Neutro
Negativo
Sentimento 3 meses
Positivo 0%
Neutro 0%
Negativo 0%

Não recebemos notícias recentes sobre INFI

Gráficos de preços implementados com Lightweight Charts™